Sign in

CIK 0001818794 · Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364883909
Phone
(781) 786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
  1. 3/A Insider 3/A
  2. 4 Derivatives Options or other derivatives
  3. SC 13G Stake Amended Statement of Ownership
  4. 144 Insider Sale of Securities
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 8-K Event Executive or director change
  8. 4 Planned sale Chief Operating Officer sold 29,491 shares at an average $26.59 ($784,248)
  9. 4 Planned sale Chief Business Officer sold 109,601 shares at an average $26.11 ($2,861,373)
  10. 4 Planned sale Chief Medical Officer sold 2,615 shares at an average $25.65 ($67,082)
  11. 4 Planned sale SVP, Head of Finance & Admin. sold 88,924 shares at an average $26.19 ($2,329,007)
  12. 4 Planned sale CEO & President sold 429,730 shares at an average $25.89 ($11,125,776)
  13. 4 Planned sale Chief Scientific Officer sold 2,081 shares at $25.70 ($53,482)
  14. 144 Insider Sale of Securities
  15. 4 Planned sale CEO & President sold 9,086 shares at $25.85 ($234,873)
  16. 4 Planned sale Chief Scientific Officer sold 2,373 shares at $25.85 ($61,342)
  17. 4 Planned sale Chief Operating Officer sold 1,591 shares at $25.85 ($41,127)
  18. 4 Planned sale Chief Medical Officer sold 9,921 shares at an average $25.86 ($256,585)
  19. 4 Planned sale Chief Business Officer sold 2,434 shares at $25.85 ($62,919)
  20. 4 Planned sale SVP, Head of Finance & Admin. sold 2,273 shares at $25.85 ($58,757)

Page 22 of 40 · 796 filings